MiniMed’s (MMED) IPO, Modular Medical’s (MODD) financing sprint, and Insulet’s (PODD) new data readout together sketch a surprisingly upbeat picture for diabetes tech investors watching the next leg of insulin-delivery innovation.
Diabetes Tech Steps Into the Spotlight
In early March, MiniMed Group,…
Nvidia’s GTC 2026 is less a tech conference and more a macroeconomic indicator with catering at this point, and CEO Jensen Huang’s keynote in San Jose is the closest thing Wall Street has to appointment television. Expectations are tuned, once again, to…
New York City woke up this week to a headline it doesn’t particularly enjoy: its first documented case of severe mpox, specifically the clade I strain associated with more serious disease and higher mortality. Health officials confirmed that the patient had recently…
Wall Street opened the week in an oddly good mood, as if the market decided that worrying about everything, all at once, was bad for performance. Stocks climbed on Monday while oil prices eased, even as President Trump publicly prodded U.S. allies…
In an AI market obsessed with GPUs and stardust, Nokia (NOK) is quietly reminding investors that none of this magic moves without serious plumbing. While Nvidia (NVDA) prepares to headline its GTC 2026 “Woodstock of AI” showcase, the chip giant has already…
Joby Aviation (NASDAQ: JOBY) just turned Bay Area gridlock into a 10‑minute flex, and investors, real estate developers, and futurists are all leaning out over the metaphorical guardrail to watch. The Santa Cruz–based electric air taxi maker’s latest demo flight across San…
US stocks notched a third straight week of losses into Friday, March 13, 2026, as oil’s lunge toward 100100 a barrel reignited inflation jitters, pushed out Fed rate‑cut hopes, and kept investors firmly in risk‑off mode.
Indexes: Red Week, Oil-Driven
The Dow, S&P 500,…
Biotech innovators are pioneering RNA‑optimized fusions for targeted alpha therapies (TATs), positioning themselves as first‑movers in the broader radiopharma market that is exploding with demand for precision cancer killers.
Radiopharma Market Momentum Builds Billions
The radiopharma sector, blending alpha‑particle precision with smart…
US stocks extended their slide Thursday as oil’s renewed march toward triple digits collided with war and credit worries to knock major indexes sharply lower.
Indexes: Risk-Off Takes the Wheel
The Dow Jones Industrial Average dropped roughly 739 points, or around 1.56%,…
US existing-home sales surprised to the upside in February, offering a rare dose of optimism for a housing market that has spent two years learning the meaning of the word “constrained.” Buyers, it seems, are finally willing to come out from behind…
